Regenerative Dermatology Company Forms Strategic Manufacturing Partnership with Innovigen
Robles BioCeutics, a regenerative dermatology company focused on senolytic and stem cell-powered skincare, has entered a strategic manufacturing partnership with Innovigen, a California-based formulation and production company specializing in cosmetic GMP manufacturing. The agreement represents a significant step toward bringing Robles BioCeutics’ debut product, GlowSelle™, to market.
The partnership will center on refining, scaling, and manufacturing GlowSelle™ while also laying the groundwork for future product lines. Innovigen will provide expertise in advanced formulation, quality control, and regulatory compliance, supporting the company’s efforts to translate its research into commercial-ready offerings.
"We've been very intentional about selecting a partner who shares our commitment to innovation, transparency, and results-driven formulation," said Maria Robles, CEO and Founder of Robles BioCeutics. "Innovigen brings not only technical excellence, but also the flexibility and vision needed to help us deliver a product that reflects the future of anti-aging skincare."
Under the agreement, Innovigen will assist in scaling formulations and may provide guidance on ingredient sourcing. The company will also handle contract manufacturing for GlowSelle™ and subsequent Robles BioCeutics products, encompassing production, packaging, and quality assurance. Additionally, both companies plan to explore co-development opportunities for new skincare solutions grounded in regenerative science and biotechnology, while maintaining strict confidentiality to protect proprietary information.
GlowSelle™, the flagship product of Robles BioCeutics, is designed to stimulate natural skin regeneration through senolytic and stem cell science. It incorporates growth factors derived from injury-mimicking conditions to target the visible signs of aging.
"We are highly impressed by the work of Robles BioCeutics, which has been featured in numerous peer-reviewed settings, most recently being highlighted by a presentation at the prestigious American Association of Immunologists™ meeting. This partnership is a natural fit," said Michael Wang, Founder and CEO of Innovigen. "Robles BioCeutics is pushing the boundaries of what's possible in topical skincare using regenerative sciences, and we're proud to help bring that vision to life."
The collaboration positions Robles BioCeutics to advance its research-driven vision for skincare while leveraging Innovigen’s manufacturing and regulatory expertise.